EGFR and non-small cell lung carcinoma: The NCI-H322M cells were more sensitive to OC treatments versus the wild-type EGFR NSCLC cells A549 by showing marked decrease of the total and activated levels of c-MET as suggested by Western blotting (Figure 3C,D).